Retrieve available abstracts of 206 articles: HTML format
Single Articles
January 2025
KANG SJ, Park J, Choi GS, Kim JG, et al Effects of maximum dose on local control after stereotactic body radiotherapy for
oligometastatic tumors of colorectal cancer.
PLoS One. 2025;20:e0313438. PubMedAbstract available
MAMUDU L, Sulley S, Atandoh PH, Reyes JL, et al Disparities in time to treatment initiation of invasive lung cancer among Black
and White patients in Tennessee.
PLoS One. 2025;20:e0311186. PubMedAbstract available
CHEN X, Kanhar GM, Hu S, Wu C, et al Occult metastases and survival of lung cancer by clinical diagnosis and CT
screening: A simulation study.
PLoS One. 2025;20:e0313544. PubMedAbstract available
HUANG T, Ma K, Wang Y Characterization and evaluation of the cytotoxic, antioxidant, and anti-human
lung cancer properties of copper nanoparticles green-synthesized by fennel
extract following the PI3K/AKT/Mtor signaling pathway.
PLoS One. 2025;20:e0309207. PubMedAbstract available
SOBOLEVA A, Kaznatcheev A, Cavill R, Schneider K, et al Validation of polymorphic Gompertzian model of cancer through in vitro and in
vivo data.
PLoS One. 2025;20:e0310844. PubMedAbstract available
SULLIVAN FM, Mair FS, Anderson W, Chew C, et al Five year mortality in an RCT of a lung cancer biomarker to select people for low
dose CT screening.
PLoS One. 2025;20:e0306163. PubMedAbstract available
GWON HR, Woo A, Yong SH, Park YM, et al Cross-sectional study of lung cancer patients as a potential high-risk factor for
abdominal aortic aneurysm.
PLoS One. 2025;20:e0315898. PubMedAbstract available
ABDULLAH S, Altwaijry N, Alnakhli M, ALenezi G, et al Novel methotrexate long-acting system using ambroxol coating and hydroxypropyl
methylcellulose encapsulation for preferential and enhanced lung cancer
efficiency.
PLoS One. 2025;20:e0314941. PubMedAbstract available
ANOSOVA O, Head A, Collins B, Alexiou A, et al Estimating the burden of underdiagnosis within England: A modelling study of
linked primary care data.
PLoS One. 2025;20:e0313877. PubMedAbstract available
AFZAL M, Abusalah MAHA, Shehzadi N, Absar M, et al Investigation of biometabolites and novel antimicrobial peptides derived from
promising source Cordyceps militaris and effect of non-small cell lung cancer
genes computationally.
PLoS One. 2025;20:e0310103. PubMedAbstract available
ZAPATA DONGO RJ, Fontana D, Mologni L, Faya Castillo JE, et al Inhibition of the anti-apoptotic protein BCL2 in EML4-ALK cell models as a second
proposed therapeutic target for non-small cell lung cancer.
PLoS One. 2025;20:e0308747. PubMedAbstract available
WANG Q, Luo Y, Zhao Y, Wang S, et al Automated recognition and segmentation of lung cancer cytological images based on
deep learning.
PLoS One. 2025;20:e0317996. PubMedAbstract available
JAHAN F, Haque S, Hogg J, Price A, et al Assessing the influence of the modifiable areal unit problem on Bayesian disease
mapping in Queensland, Australia.
PLoS One. 2025;20:e0313079. PubMedAbstract available
PRAKAIKIETIKUL P, Tajarenmuang P, Losuriya P, Ina N, et al Non-cancerous CT findings as predictors of survival outcome in advanced non-small
cell lung cancer patients treated with first-generation EGFR-TKIs.
PLoS One. 2025;20:e0313577. PubMedAbstract available
ZHU Q, Fei L Cross-ViT based benign and malignant classification of pulmonary nodules.
PLoS One. 2025;20:e0318670. PubMedAbstract available
SHAO K, Du F, Qiu L, Zhang Y, et al Comparative analysis of VMAT plans on Halcyon and infinity for lung cancer
radiotherapy.
PLoS One. 2025;20:e0318462. PubMedAbstract available
BARBEAU LMO, Beelen NA, Savelkouls KG, Keulers TGH, et al MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell
lung cancer.
PLoS One. 2025;20:e0316716. PubMedAbstract available
RABBY MS, Islam MM, Kumar S, Maniruzzaman M, et al Identification of potential biomarkers for lung cancer using integrated
bioinformatics and machine learning approaches.
PLoS One. 2025;20:e0317296. PubMedAbstract available
KHAN MA, Khan ZA, Husain I, Upadhyay S, et al Effects of pressure on the survival and viability of cancer cells in vitro: An
analytical study.
PLoS One. 2025;20:e0311685. PubMedAbstract available
HIGASHI S, Yamakuchi M, Hashinokuchi H, Takenouchi K, et al Adaptation to acidic conditions that mimic the tumor microenvironment,
downregulates miR-193b-3p, and induces EMT via TGFbeta2 in A549 cells.
PLoS One. 2025;20:e0318811. PubMedAbstract available
DIAO S, Wan Y, Huang D, Huang S, et al Optimizing Bi-LSTM networks for improved lung cancer detection accuracy.
PLoS One. 2025;20:e0316136. PubMedAbstract available
PAN X, Togka K, Ten Berge H, de Jong L, et al Lung cancer screening with volume computed tomography is cost-effective in
Greece.
PLoS One. 2025;20:e0316351. PubMedAbstract available
GHIROTTO L, Paci E, Bricci C, Marini S, et al Self-blaming as a barrier to lung cancer screening and smoking cessation programs
in Italy. A qualitative study.
PLoS One. 2025;20:e0318732. PubMedAbstract available
Retraction: Integrative analyses identify osteopontin, LAMB3 and ITGB1 as
critical pro-metastatic genes for lung cancer.
PLoS One. 2025;20:e0320171. PubMed
TANG S, Bao Q, Ji Q, Wang T, et al Improvement of RT-DETR model for ground glass pulmonary nodule detection.
PLoS One. 2025;20:e0317114. PubMedAbstract available
ALLEN J, Healey G, Macdonald I Lung cancer associated autoantibody responses are detectable years before
clinical presentation.
PLoS One. 2025;20:e0315220. PubMedAbstract available
LV Z, Liu P, Yang Y, Ji J, et al Correction: (-)-Epicatechin regulates endoplasmic reticulum stress and promotes
ferroptosis in lung cancer cells via the PERK/eIF2alpha/ATF4 signaling pathway.
PLoS One. 2025;20:e0320174. PubMedAbstract available
HOSSAIN MS, Basak N, Mollah MA, Nahiduzzaman M, et al Ensemble-based multiclass lung cancer classification using hybrid CNN-SVD feature
extraction and selection method.
PLoS One. 2025;20:e0318219. PubMedAbstract available
LI C, Zhong S, Chen J, Mu X, et al TsRNA-49-73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer.
PLoS One. 2025;20:e0320187. PubMedAbstract available
ZHANG DT, Shi GX, Jia JY, Tan FW, et al Electroacupuncture for acute postoperative pain during coughing after
video-assisted thoracoscopic surgery: study protocol for a pilot randomized
controlled trial.
PLoS One. 2025;20:e0316698. PubMedAbstract available
ZHENG Z, Zhu H, Fang L Tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for
extensive-stage small cell lung cancer: A cost-effectiveness analysis.
PLoS One. 2025;20:e0320189. PubMedAbstract available
Correction: Capture of circulating metastatic cancer cell clusters from lung
cancer patients can reveal unique genomic profiles and potential anti-metastatic
molecular targets: A proof-of-concept study.
PLoS One. 2025;20:e0321150. PubMedAbstract available
JAVRUSHYAN H, Ginovyan M, Harutyunyan T, Gevorgyan S, et al Elucidating the impact of Hypericum alpestre extract and L-NAME on the PI3K/Akt
signaling pathway in A549 lung adenocarcinoma and MDA-MB-231 triple-negative
breast cancer cells.
PLoS One. 2025;20:e0303736. PubMedAbstract available
WANG M, Jiang W, Wei T, Li Z, et al Dynamic changes and metabolic function of intestinal flora in patients with
postoperative pneumonia after lung cancer surgery.
PLoS One. 2025;20:e0321016. PubMedAbstract available
KIM MS, Kim MS Deubiquitination of epidermal growth factor receptor by ubiquitin-specific
peptidase 54 enhances drug sensitivity to gefitinib in gefitinib-resistant
non-small cell lung cancer cells.
PLoS One. 2025;20:e0320668. PubMedAbstract available
HAO L, Zhang J, Di Y, Qi Z, et al Predicting a failure of postoperative thromboprophylaxis in non-small cell lung
cancer: A stacking machine learning approach.
PLoS One. 2025;20:e0320674. PubMedAbstract available
EL-TANANI M, Satyam SM, Rabbani SA, Obeidat RM, et al Decoding oncogenic secrets of regulator of chromosome condensation 1: A
breakthrough mechanistic evidence from breast and lung cancer models.
PLoS One. 2025;20:e0319748. PubMedAbstract available
PRAKAIKIETIKUL P, Wannasopha Y, Euathrongchit J, Tantraworasin A, et al CT features and histogram analysis of non-contrast images for differentiating
malignant and benign mediastinal lymph nodes in Non-Small Cell Lung Cancer
(NSCLC).
PLoS One. 2025;20:e0321921. PubMedAbstract available
GAO C, Liu M, Sun Y, Zhao Z, et al Association between advanced lung cancer inflammation index and gallstone
prevalence among U.S. adults: A population-based study.
PLoS One. 2025;20:e0321733. PubMedAbstract available
KUO P, Elboudwarej E, Zavodovskaya M, Lin KW, et al Trop-2 expression in non-small cell lung cancer.
PLoS One. 2025;20:e0321555. PubMedAbstract available
PONGPIACHAN S, Tipmanee D, Khumsup C, Hirunyatrakul P, et al Size-segregated analysis of PAHs in Urban air: Source apportionment and health
risk assessment in an Urban canal-adjacent environment.
PLoS One. 2025;20:e0320405. PubMedAbstract available
MALIK V, Mittal R, Gupta D, Juneja S, et al Optimizing chemotherapeutic targets in non-small cell lung cancer with transfer
learning for precision medicine.
PLoS One. 2025;20:e0319499. PubMedAbstract available
YU W, Long L, Hou Q, Yi B, et al Development of a nomogram for overall survival prediction in primary upper lobe
lung cancer patients: A SEER population-based analysis.
PLoS One. 2025;20:e0321955. PubMedAbstract available
MOUSAVI SF, Masoudi S, Rezaei N, Pourghazi F, et al Survival assessment and pre-diagnostic risk factors for lung cancer incidence:
Insights from the Golestan Cohort Study.
PLoS One. 2025;20:e0320931. PubMedAbstract available
DE-TORRES JP, Giron-Flamenco JJ, Rodriguez M, de la Fuente-Ano A, et al Exploring the impact of surgical treatment for lung cancer in patients with
Airway Obstruction from a Lung Cancer Screening Program.
PLoS One. 2025;20:e0320704. PubMedAbstract available
OTERO-CARRASCO B, Nevado PT, Munoz RA, Ferreiro GD, et al Finding patterns in lung cancer protein sequences for drug repurposing.
PLoS One. 2025;20:e0322546. PubMedAbstract available
RAO S, Wu H, Zhang G, Dong W, et al A comparative analysis of the burden, trends and inequalities of tracheal,
bronchus, and lung cancer in India from 2000 to 2021: A systematic analysis for
the Global Burden of Disease study 2021.
PLoS One. 2025;20:e0322646. PubMedAbstract available
SALOMONSSON A, Ehinger D, Jonsson M, Botling J, et al Gene expression-based identification of prognostic markers in lung
adenocarcinoma.
PLoS One. 2025;20:e0310232. PubMedAbstract available
LI Z, Zhu Z, Wang P, Hou C, et al Diagnostic, prognostic, and immunological roles of FUT8 in lung adenocarcinoma
and lung squamous cell carcinoma.
PLoS One. 2025;20:e0321756. PubMedAbstract available
YIN X, Liang HW, Liu Y, Huang W, et al Lobectomy versus sublobar resection on survival in patients with stage T1-2N0M0
small cell lung cancer.
PLoS One. 2025;20:e0324315. PubMedAbstract available
Retraction: Efficient lung cancer detection using computational intelligence and
ensemble learning.
PLoS One. 2025;20:e0324356. PubMed
PHILIBERT R, Beach SRH, Mills JA, Dawes K, et al Epigenetic assessments of alcohol consumption predict mortality in smokers at
risk for lung cancer in the prostate, lung, colorectal and ovarian cancer
screening trial.
PLoS One. 2025;20:e0322783. PubMedAbstract available
PEREZ AL, Zamora M, Bahena M, Aramburo-Williams R, et al The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice
by reducing pulmonary vascular permeability.
PLoS One. 2025;20:e0316983. PubMedAbstract available
ZHANG Y, Hu Y, Xi J, Wu B, et al Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small
cell lung cancer.
PLoS One. 2025;20:e0319357. PubMedAbstract available
JIM JR, Rayed ME, Mridha MF, Nur K, et al XLLC-Net: A lightweight and explainable CNN for accurate lung cancer
classification using histopathological images.
PLoS One. 2025;20:e0322488. PubMedAbstract available
ZHENG Z, Zhu H, Fang L Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for
first-line treatment of extensive-stage small cell lung cancer.
PLoS One. 2025;20:e0325171. PubMedAbstract available
WANG X, Sharpnack J, Lee TCM Improving lung cancer diagnosis and survival prediction with deep learning and CT
imaging.
PLoS One. 2025;20:e0323174. PubMedAbstract available
ABUMANSOUR H, Abusara OH, Abu-Sini M, Khalil W, et al Thionated levofloxacin derivative: Potential repurposing for cancer treatment and
synergism with doxorubicin on doxorubicin-resistant lung cancer cells.
PLoS One. 2025;20:e0324930. PubMedAbstract available
January 2024
ZHANG J, Huang X, Liu Y, Han Y, et al GAN-based medical image small region forgery detection via a two-stage cascade
framework.
PLoS One. 2024;19:e0290303. PubMedAbstract available
GAO X, Tang M, Tian S, Li J, et al ncRNAs-mediated TIMELESS overexpression in lung adenocarcinoma correlates with
reduced tumor immune cell infiltration and poor prognosis.
PLoS One. 2024;19:e0296829. PubMedAbstract available
Expression of Concern: Over-Expression of LSD1 Promotes Proliferation, Migration
and Invasion in Non-Small Cell Lung Cancer.
PLoS One. 2024;19:e0298436. PubMed
KANG J, Zhang J, Tian Z, Xu Y, et al The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus
chemotherapy for non-small cell lung cancer: An updated systematic review and
meta-analysis.
PLoS One. 2024;19:e0276318. PubMedAbstract available
FAYA CASTILLO JE, Zapata Dongo RJ, Wong Chero PA, Infante Varillas SF, et al Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the
treatment of non-small cell lung cancer.
PLoS One. 2024;19:e0295966. PubMedAbstract available
Expression of Concern: Comparison of 18F-FDG PET/CT and DWI for detection of
mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
PLoS One. 2024;19:e0299045. PubMed
TIAN P, Du D, Yang L, Zhou N, et al SP3-induced Timeless transcription contributes to cell growth of lung
adenocarcinoma cells.
PLoS One. 2024;19:e0298295. PubMedAbstract available
CHEN Q, Li W, Cai N, Chen W, et al Comparison of postoperative complications in mediastinal lymph node dissection
versus mediastinal lymph node sampling for early stage non-small cell lung
cancer: Protocol for a systematic review and meta-analysis.
PLoS One. 2024;19:e0298368. PubMedAbstract available
MORI S, Ueki Y, Hasegawa M, Nakamura K, et al Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and
mortality in rheumatoid arthritis: A multicenter retrospective cohort study.
PLoS One. 2024;19:e0298573. PubMedAbstract available
WANG H, Tang H, Yuan S, Liang C, et al IL-17A deficiency inhibits lung cancer-induced osteoclastogenesis by promoting
apoptosis of osteoclast precursor cells.
PLoS One. 2024;19:e0299028. PubMedAbstract available
YOO SJ, Park YS, Choi H, Kim DS, et al Prospective evaluation of deep learning image reconstruction for Lung-RADS and
automatic nodule volumetry on ultralow-dose chest CT.
PLoS One. 2024;19:e0297390. PubMedAbstract available
AJENU EO, Seideneck AM, Pandellapalli E, Shinsky EM, et al ABCG2 transporter reduces protein aggregation in cigarette smoke
condensate-exposed A549 lung cancer cells.
PLoS One. 2024;19:e0297661. PubMedAbstract available
KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al Protocol to measure validity and reliability of colorectal, breast, cervical and
lung cancer screening questions from the 2021 National Health Interview Survey:
Methodology and design.
PLoS One. 2024;19:e0297773. PubMedAbstract available
AHMAD A, Kulachi MO, Farman M, Junjua MU, et al Mathematical modeling and control of lung cancer with IL2 cytokine and anti-PD-L1
inhibitor effects for low immune individuals.
PLoS One. 2024;19:e0299560. PubMedAbstract available
LEE YJ, Kang N, Nam J, Lee EG, et al The preventative effects of statin on lung cancer development in patients with
idiopathic pulmonary fibrosis using the National Health Insurance Service
Database in Korea.
PLoS One. 2024;19:e0299484. PubMedAbstract available
MALIK H, Anees T Multi-modal deep learning methods for classification of chest diseases using
different medical imaging and cough sounds.
PLoS One. 2024;19:e0296352. PubMedAbstract available
XUE Y, Zhang D, Jia L, Yang W, et al Integrating image and gene-data with a semi-supervised attention model for
prediction of KRAS gene mutation status in non-small cell lung cancer.
PLoS One. 2024;19:e0297331. PubMedAbstract available
MAJUMDER S, Gautam N, Basu A, Sau A, et al MENet: A Mitscherlich function based ensemble of CNN models to classify lung
cancer using CT scans.
PLoS One. 2024;19:e0298527. PubMedAbstract available
ZHANG L, Xu L, Chen Z, You H, et al Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic
surgery in lung adenocarcinoma patients.
PLoS One. 2024;19:e0297742. PubMedAbstract available
LI Q, Wei Z, Zhang Y, Zheng C, et al Causal role of metabolites in non-small cell lung cancer: Mendelian randomization
(MR) study.
PLoS One. 2024;19:e0300904. PubMedAbstract available
MOMOKI Y, Ichinose A, Nakamura K, Iwano S, et al Development of automatic generation system for lung nodule finding descriptions.
PLoS One. 2024;19:e0300325. PubMedAbstract available
HAN H, Huang H, Chen AP, Tang Y, et al High CASC expression predicts poor prognosis of lung cancer: A systematic review
with meta-analysis.
PLoS One. 2024;19:e0292726. PubMedAbstract available
ZHANG Y, Liu H, Chang C, Yin Y, et al Machine learning for differentiating lung squamous cell cancer from
adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT
radiomics.
PLoS One. 2024;19:e0300170. PubMedAbstract available
LV M, Li X, Yin Z, Yang H, et al Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic
biomarker associated with tumor immunity in non-small-cell lung cancer.
PLoS One. 2024;19:e0294227. PubMedAbstract available
LE ROUX O, Everitt JI, Counter CM p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
PLoS One. 2024;19:e0292189. PubMedAbstract available
TRIPLETTE M, Kross EK, Snidarich M, Shahrir S, et al An alternating-intervention pilot trial on the impact of an informational handout
on patient-reported outcomes and follow-up after lung cancer screening.
PLoS One. 2024;19:e0300352. PubMedAbstract available
MAY T, Clement MS, Halait H, Kohlmann A, et al Performance characteristics of a polymerase chain reaction-based assay for the
detection of EGFR mutations in plasma cell-free DNA from patients with non-small
cell lung cancer using cell-free DNA collection tubes.
PLoS One. 2024;19:e0295987. PubMedAbstract available
ZHANG H, Cheng X, Guo W, Zheng C, et al Metastasis patterns and prognosis in young gastric cancer patients: A propensity
score?matched SEER database analysis.
PLoS One. 2024;19:e0301834. PubMedAbstract available
RADWAN AA, Alanazi F, Al-Dhfyan A Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer
therapeutics: In silico screening and in vitro evaluation.
PLoS One. 2024;19:e0298326. PubMedAbstract available
LI H, Huntington S, Gross C, Wang SY, et al Immunotherapy utilization patterns in patients with advanced cancer and
autoimmune disease.
PLoS One. 2024;19:e0300789. PubMedAbstract available
ZHANG MS, Yeh YC, Huang HN, Lin LW, et al The association of EGFR amplification with aberrant exon 20 insertion report
using the cobas EGFR Mutation Test v2.
PLoS One. 2024;19:e0301120. PubMedAbstract available
KONG Y, Hong L, Xu XC, Chen YF, et al The relative risk of immune checkpoint inhibitor pneumonitis in advanced
non-small- cell lung cancer: Meta-analyses of controlled clinical trials.
PLoS One. 2024;19:e0301931. PubMedAbstract available
WU B, Zhang X, Feng N, Hu Z, et al Treatment strategies for stage IA non-small cell lung cancer: A SEER-based
population study.
PLoS One. 2024;19:e0298470. PubMedAbstract available
HUH Y, Sohn YJ, Kim HR, Chun H, et al Sex differences in prognosis factors in patients with lung cancer: A nationwide
retrospective cohort study in Korea.
PLoS One. 2024;19:e0300389. PubMedAbstract available
BAK SH, Park J, Lee S, Kim JH, et al Clinical usability of 3D gradient-echo-based ultrashort echo time imaging: Is it
enough to facilitate diagnostic decision in real-world practice?
PLoS One. 2024;19:e0296696. PubMedAbstract available
HAN KT, Kim S Does improved nurse staffing impact patient outcomes in cancer? Association
between chronic diseases and mortality among older adult patients with lung
cancer in Korea.
PLoS One. 2024;19:e0301010. PubMedAbstract available
THU YM, Suzawa K, Tomida S, Ochi K, et al PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung
cancer.
PLoS One. 2024;19:e0300644. PubMedAbstract available
CHANG GC, Shih JY, Yu CJ, Chao HS, et al Real-world osimertinib pretreatment experience in patients with epidermal growth
factor receptor T790M mutation-positive locally advanced or metastatic non-small
cell lung cancer.
PLoS One. 2024;19:e0303046. PubMedAbstract available
LEE ACH, Madariaga MLL, Lee SM, Ferguson MK, et al The risk analysis index is an independent predictor of outcomes after lung cancer
resection.
PLoS One. 2024;19:e0303281. PubMedAbstract available
WANG H, Zhu H, Ding L, Yang K, et al Attention pyramid pooling network for artificial diagnosis on pulmonary nodules.
PLoS One. 2024;19:e0302641. PubMedAbstract available
N KACHOUIE N, Deebani W, Shutaywi M, Christiani DC, et al Lung cancer clustering by identification of similarities and discrepancies of DNA
copy numbers using maximal information coefficient.
PLoS One. 2024;19:e0301131. PubMedAbstract available
Editorial Note: Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by
Targeting PGE2-Mediated Activation of beta-Catenin Signaling.
PLoS One. 2024;19:e0303600. PubMed
BIANCHI F, Le Noci V, Bernardo G, Gagliano N, et al Cigarette smoke sustains immunosuppressive microenvironment inducing M2
macrophage polarization and viability in lung cancer settings.
PLoS One. 2024;19:e0303875. PubMedAbstract available
LUO W, Chang G, Lin D, Xie H, et al 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit
lung cancer cell proliferation and migration.
PLoS One. 2024;19:e0303186. PubMedAbstract available
ZHONG J, Hua Y, Zou S, Wang B, et al Juglone triggers apoptosis of non-small cell lung cancer through the reactive
oxygen species -mediated PI3K/Akt pathway.
PLoS One. 2024;19:e0299921. PubMedAbstract available
BOUKANSA S, Mouhrach I, El Agy F, El Bardai S, et al Clinicopathological and prognostic implications of EGFR mutations subtypes in
Moroccan non-small cell lung cancer patients: A first report.
PLoS One. 2024;19:e0298721. PubMedAbstract available
PATHAN RK, Shorna IJ, Hossain MS, Khandaker MU, et al The efficacy of machine learning models in lung cancer risk prediction with
explainability.
PLoS One. 2024;19:e0305035. PubMedAbstract available
CUI R, Li Y, Yu X, Wei C, et al Efficacy and safety of concurrent immune checkpoint inhibitors combined with
radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A
systematic review and single-arm meta-analysis.
PLoS One. 2024;19:e0304941. PubMedAbstract available
ALSHEHRI MA, Asiri SA, Helmi N, Baeissa HM, et al Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer
structural maintenance and suppression proteins through pharmacokinetics, QM-DFT,
and multiscale MD simulation studies.
PLoS One. 2024;19:e0303784. PubMedAbstract available
YU H, Wang Y, Yue X, Zhang H, et al Influence of the atmospheric environment on spatial variation of lung cancer
incidence in China.
PLoS One. 2024;19:e0305345. PubMedAbstract available
JARRY U, Bostoen M, Archambeau J, Pineau R, et al Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor
development in orthotopic murine models of non-small lung cancer.
PLoS One. 2024;19:e0304914. PubMedAbstract available
WANG C, Zhu X, Zheng M, Chen Y, et al Pan-cancer analysis of PSCA that is associated with immune infiltration and
affects patient prognosis.
PLoS One. 2024;19:e0298469. PubMedAbstract available
WANG B, Wang J, Sun T, Ding Y, et al Lu's approach for video-assisted thoracoscopic surgery.
PLoS One. 2024;19:e0300632. PubMedAbstract available
GONG S, Li G, Li D, Liu Y, et al The risk for subsequent primary lung cancer after cervical carcinoma: A
quantitative analysis based on 864,627 cases.
PLoS One. 2024;19:e0305670. PubMedAbstract available
Correction: Efficient gene transfection to lung cancer cells via
Folate-PEI-Sorbitol gene transporter.
PLoS One. 2024;19:e0306665. PubMedAbstract available
USHER-SMITH JA, Masson G, Godoy A, Burge SW, et al Acceptability of adding a non-contrast abdominal CT scan to screen for kidney
cancer and other abdominal pathology within a community-based CT screening
programme for lung cancer: A qualitative study.
PLoS One. 2024;19:e0300313. PubMedAbstract available
PARK J, Rho MJ, Moon MH Enhanced deep learning model for precise nodule localization and recurrence risk
prediction following curative-intent surgery for lung cancer.
PLoS One. 2024;19:e0300442. PubMedAbstract available
LOTFI F, Rashidian H, Hadji M, Mohebbi E, et al Exposure to second-hand smoke and risk of lung cancer among Iranian population: A
multicenter case-control study.
PLoS One. 2024;19:e0306517. PubMedAbstract available
HAO H, Maeda Y, Fukazawa T, Yamatsuji T, et al Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule
Compound to Treat Non-Small Cell Lung Cancer.
PLoS One. 2024;19:e0307052. PubMedAbstract available
VAN DEN BOSSCHE J, De Laere M, Deschepper K, Germonpre P, et al Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into
standard-of-care first-line treatment for patients with epithelioid malignant
pleural mesothelioma-Protocol of the Immuno-MESODEC study.
PLoS One. 2024;19:e0307204. PubMedAbstract available
ARMIJO N, Salas C, Espinoza N, Espinoza M, et al Budget impact analysis of durvalumab consolidation therapy vs no consolidation
therapy after chemoradiotherapy in stage III non-small cell lung cancer in the
context of the Chilean health care system.
PLoS One. 2024;19:e0307473. PubMedAbstract available
CHEN XP, He SX, Chen MY, Chen FB, et al Meta-analysis of the accuracy for RASSF1A methylation in bronchial aspirates for
the diagnosis of lung cancer.
PLoS One. 2024;19:e0299447. PubMedAbstract available
SIL BK, Jamiruddin MR, Paul PK, Aekwattanaphol N, et al Ascorbic acid as serine protease inhibitor in lung cancer cell line and human
serum albumin.
PLoS One. 2024;19:e0303706. PubMedAbstract available
LIANG Y, Maeda O, Kondo C, Nishida K, et al Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of
immune checkpoint inhibitors among patients with lung adenocarcinoma.
PLoS One. 2024;19:e0307580. PubMedAbstract available
MATSUMOTO H, Fukushima T, Kobayashi N, Higashino Y, et al High red blood cell distribution width attenuates the effectiveness of Immune
checkpoint inhibitor therapy: An exploratory study using a clinical data
warehouse.
PLoS One. 2024;19:e0299760. PubMedAbstract available
HUMMELINK K, van der Noort V, Muller M, Schouten RD, et al Head-to-head comparison of composite and individual biomarkers to predict
clinical benefit to PD-1 blockade in non-small cell lung cancer.
PLoS One. 2024;19:e0293707. PubMedAbstract available
KOUHMAREH K, Martin E, Finlay D, Bhadada A, et al Capture of circulating metastatic cancer cell clusters from lung cancer patients
can reveal unique genomic profiles and potential anti-metastatic molecular
targets: A proof-of-concept study.
PLoS One. 2024;19:e0306450. PubMedAbstract available
SCHOUTEN RD, Schouten I, Schuurbiers MMF, van der Noort V, et al Optimising primary molecular profiling in non-small cell lung cancer.
PLoS One. 2024;19:e0290939. PubMedAbstract available
KISS N, Ugalde A, Prado CM, Denehy L, et al Living with low muscle mass and its impact throughout curative treatment for lung
cancer: A qualitative study.
PLoS One. 2024;19:e0304003. PubMedAbstract available
PETERS HA, Weiss D, Boschheidgen M, Mamlins E, et al Prognostic potential of integrated morphologic and metabolic parameters of
pre-therapeutic [18F]FDG-PET/CT regarding progression-free survival (PFS) and
overall survival (OS) in NSCLC-patients.
PLoS One. 2024;19:e0307998. PubMedAbstract available
SAJJADI SF, Salehi N, Sadeghi M Comprehensive integrated single-cell RNA sequencing analysis of brain metastasis
and glioma microenvironment: Contrasting heterogeneity landscapes.
PLoS One. 2024;19:e0306220. PubMedAbstract available
ITO M, Koido S, Iwamoto T, Morimoto S, et al Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with
immunoproteasome inhibitors.
PLoS One. 2024;19:e0308330. PubMedAbstract available
SARAJI A, Wulf K, Stegmann-Frehse J, Kang D, et al Comprehensive transcriptomic analysis of prostate cancer lung metastases.
PLoS One. 2024;19:e0306525. PubMedAbstract available
ANANDAKRISHNAN R, Shahidi R, Dai A, Antony V, et al An approach for developing a blood-based screening panel for lung cancer based on
clonal hematopoietic mutations.
PLoS One. 2024;19:e0307232. PubMedAbstract available
MA Y, Li Z, Li D, Zheng B, et al G0 arrest gene patterns to predict the prognosis and drug sensitivity of patients
with lung adenocarcinoma.
PLoS One. 2024;19:e0309076. PubMedAbstract available
KILDAHL-ANDERSEN A, Hofstad EF, Solberg OV, Sorger H, et al Navigated ultrasound bronchoscopy with integrated positron emission tomography-A
human feasibility study.
PLoS One. 2024;19:e0305785. PubMedAbstract available
YU SC, Huang JY, Cheng YF, Cheng CY, et al Prognostic factors in clinical stage IIIA small cell lung cancer: An analysis of
a population-based cancer registry in Taiwan.
PLoS One. 2024;19:e0297399. PubMedAbstract available
LAI GS, Chen CS, Cheng JC, Li JR, et al Impact of different visceral metastatic sites on survival in metastatic prostate
cancer patients.
PLoS One. 2024;19:e0309941. PubMedAbstract available
LIN L, Deng L, Bao Y Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells
and investigating their underlying mechanisms via high-throughput sequencing.
PLoS One. 2024;19:e0307954. PubMedAbstract available
Correction: The efficacy of machine learning models in lung cancer risk
prediction with explainability.
PLoS One. 2024;19:e0310604. PubMedAbstract available
PIRES DC, Arueira Chaves L, Dantas Cardoso CH, Faria LV, et al Effects of low dose computed tomography (LDCT) on lung cancer screening on
incidence and mortality in regions with high tuberculosis prevalence: A
systematic review.
PLoS One. 2024;19:e0308106. PubMedAbstract available
WU X, Li W, Chen Y Differences in the risk association of TERT-CLPTM1L rs4975616 (A>G) with lung
cancer between Caucasian and Asian populations: A meta-analysis.
PLoS One. 2024;19:e0309747. PubMedAbstract available
FANIZZI A, Fadda F, Maddalo M, Saponaro S, et al Developing an ensemble machine learning study: Insights from a multi-center
proof-of-concept study.
PLoS One. 2024;19:e0303217. PubMedAbstract available
GEUBBELMANS M, Claes J, Nijsten K, Gervois P, et al Optimization of whole slide imaging scan settings for computer vision using human
lung cancer tissue.
PLoS One. 2024;19:e0309740. PubMedAbstract available
KIM T, Choe J, Shin SH, Jeong BH, et al Repeated rebiopsy for detection of EGFR T790M mutation in patients with
advanced-stage lung adenocarcinoma: Associated factors and treatment outcomes of
Osimertinib.
PLoS One. 2024;19:e0310079. PubMedAbstract available
JAIN R, Singh P, Abdelkader M, Boulila W, et al Efficient lung cancer detection using computational intelligence and ensemble
learning.
PLoS One. 2024;19:e0310882. PubMedAbstract available
DJERIDI Z, Ghouar A, Boulares H, Bouye M, et al Applications of the prediction of satisfaction design for monitoring single-arm
phase II trials.
PLoS One. 2024;19:e0305814. PubMedAbstract available
HUANG H, Li L, Tong L, Luo H, et al Perioperative PD-1/PD-L1 inhibitors for resectable non-small cell lung cancer: A
meta-analysis based on randomized controlled trials.
PLoS One. 2024;19:e0310808. PubMedAbstract available
XIE J, He Y, Che S, Zhao W, et al Differential diagnosis of benign and lung adenocarcinoma presenting as larger
solid nodules and masses based on multiscale CT radiomics.
PLoS One. 2024;19:e0309033. PubMedAbstract available
NAGAMINE H, Yashiro M, Mizutani M, Sugimoto A, et al Insulin-like growth factor 1 receptor expression correlates with programmed death
ligand 1 expression and poor survival in non-small cell lung cancer.
PLoS One. 2024;19:e0297397. PubMedAbstract available
STOVERUD KH, Bouget D, Pedersen A, Leira HO, et al AeroPath: An airway segmentation benchmark dataset with challenging pathology and
baseline method.
PLoS One. 2024;19:e0311416. PubMedAbstract available
NDUAGUBA SO, Kelly KM Multilevel factors associated with delays in screening, diagnosis, and treatment
for lung cancer-A mixed methods systematic review protocol.
PLoS One. 2024;19:e0309196. PubMedAbstract available
PENG J, Xu H, Liu Q Sintilimab plus chemotherapy with or without bevacizumab biosimilar IBI305 in
EGFR-mutated non-squamous NSCLC patients who progressed on EGFR TKI therapy: A
China-based cost-effectiveness analysis.
PLoS One. 2024;19:e0312133. PubMedAbstract available
CHEN H, Hu XB, Zhou J, He CY, et al Association of chronic obstructive pulmonary disease with risk of lung cancer in
individuals aged 40 years and older: A cross-sectional study based on NHANES
2013-2018.
PLoS One. 2024;19:e0311537. PubMedAbstract available
GREGORY MD, Ofosu-Asante K, Lazarte JMS, Puente PE, et al Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl
amide inhibitors activates the MAPK pathway, inhibits cell migration and induces
apoptosis.
PLoS One. 2024;19:e0312563. PubMedAbstract available
MAHJABEEN A, Hasan MZ, Rahman MT, Islam MA, et al Genetic insights into the connection between pulmonary TB and non-communicable
diseases: An integrated analysis of shared genes and potential treatment targets.
PLoS One. 2024;19:e0312072. PubMedAbstract available
LV Z, Liu P, Yang Y, Ji J, et al (-)-Epicatechin regulates endoplasmic reticulum stress and promotes ferroptosis
in lung cancer cells via the PERK/eIF2alpha/ATF4 signaling pathway.
PLoS One. 2024;19:e0313010. PubMedAbstract available
SUZUKI S, Yashiro M, Izumi N, Tsukioka T, et al Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small
cell lung cancer based on [18F]FDG PET/CT.
PLoS One. 2024;19:e0312846. PubMedAbstract available
PAVEL MA, Islam R, Babor SB, Mehadi R, et al Non-small cell lung cancer detection through knowledge distillation approach with
teaching assistant.
PLoS One. 2024;19:e0306441. PubMedAbstract available
YANG Y, Li J, Wang Y, Luo L, et al Prognostic value of the systemic immune-inflammation index in lung cancer
patients receiving immune checkpoint inhibitors: A meta-analysis.
PLoS One. 2024;19:e0312605. PubMedAbstract available
Retraction: Differential Expression of the RANKL/RANK/OPG System Is Associated
with Bone Metastasis in Human Non-Small Cell Lung Cancer.
PLoS One. 2024;19:e0314046. PubMed
LIAO Y, Zhou Y, Zhou X, Chen J, et al Gastroesophageal reflux disease and risk of incident lung cancer: A large
prospective cohort study in UK Biobank.
PLoS One. 2024;19:e0311758. PubMedAbstract available
CAI S, Yang W, Luo H, Li Z, et al Clinical features and prognostic factors of IV combined small cell lung cancer: A
propensity score matching analysis.
PLoS One. 2024;19:e0313221. PubMedAbstract available
SLOMKA J, Berthou H, Mansuet-Lupo A, Blons H, et al Clinical and molecular characteristics associated with high PD-L1 expression in
EGFR-mutated lung adenocarcinoma.
PLoS One. 2024;19:e0307161. PubMedAbstract available
DONG Y, Li S, Che G Is it safe and feasible to use multi-lateral-pores drainage strategy after
video-assisted thoracoscopic surgery?
PLoS One. 2024;19:e0313176. PubMedAbstract available
BONERT M, Schittenhelm J, Begum H, Lu JQ, et al Neuroanatomical location of lung cancer brain metastases in 234 patients with a
focus on cancer subtyping and biomarkers.
PLoS One. 2024;19:e0314205. PubMedAbstract available
ZHANG E, Feng X, Liu F, Zhang P, et al Correction: Roles of PI3K/Akt and c-Jun Signaling Pathways in Human
Papillomavirus Type 16 Oncoprotein-Induced HIF-1alpha, VEGF, and IL-8 Expression and
In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells.
PLoS One. 2024;19:e0314378. PubMedAbstract available
YADAV DP, Sharma B, Webber JL, Mehbodniya A, et al EDTNet: A spatial aware attention-based transformer for the pulmonary nodule
segmentation.
PLoS One. 2024;19:e0311080. PubMedAbstract available
GUIBIN D, Xiaolan S, Wei Z, Xiaoli L, et al Prediction of iodine-125 seed implantation efficacy in lung cancer using an
enhanced CT-based nomogram model.
PLoS One. 2024;19:e0313570. PubMedAbstract available
WANG S, Yan H, Wen J, Zhou Z, et al Risk factors for conversion to thoracotomy in patients with lung cancer
undergoing video-assisted thoracoscopic surgery: A meta-analysis.
PLoS One. 2024;19:e0313236. PubMedAbstract available
ARUNACHALAM A, Sura S, Murphy J, Conkling P, et al Real-world treatment patterns and outcomes among unresectable stage III non-small
cell lung cancer.
PLoS One. 2024;19:e0314156. PubMedAbstract available
JIANG HN, Zeng B, Zhang Y, Daskoulidou N, et al Correction: Involvement of TRPC Channels in Lung Cancer Cell Differentiation and
the Correlation Analysis in Human Non-Small Cell Lung Cancer.
PLoS One. 2024;19:e0315242. PubMedAbstract available
WEINSTEIN SJ, Parisi D, Mondul AM, Layne TM, et al Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in
the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
PLoS One. 2024;19:e0315252. PubMedAbstract available
JALILIAN H, Heydari S, Javanshir E, Jamebozorgi K, et al Hospitalization costs and out-of-pocket (OOP) payment in lung cancer patients in
Iran: Health Sector Evolution Plan (HSEP) has reduced OOP payments and improved
financial protection.
PLoS One. 2024;19:e0297934. PubMedAbstract available
CHATWICHIEN J, Semakul N, Yimklan S, Suwanwong N, et al Lutein derived from Xenostegia tridentata exhibits anticancer activities against
A549 lung cancer cells via hyaluronidase inhibition.
PLoS One. 2024;19:e0315570. PubMedAbstract available
YUAN S, Ou W, Mi X, Hou J, et al Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting
LDHA-targeted metabolic pathways.
PLoS One. 2024;19:e0310825. PubMedAbstract available
KLIMONTOVA M, Zhang H, Campos-Laborie F, Webster N, et al THUMPD3 regulates alternative splicing of ECM transcripts in human lung cancer
cells and promotes proliferation and migration.
PLoS One. 2024;19:e0314655. PubMedAbstract available
HANAOKA S, Nomura Y, Hayashi N, Sato I, et al Deep generative abnormal lesion emphasization validated by nine radiologists and
1000 chest X-rays with lung nodules.
PLoS One. 2024;19:e0315646. PubMedAbstract available
ZHANG H, Liu S, Zhang J, Wang Y, et al CD47 expression in non-small cell lung cancer and its relationship with
tumor-associated macrophage infiltration.
PLoS One. 2024;19:e0314228. PubMedAbstract available
ROMASZKO-WOJTOWICZ A, Doboszynska A, Piechnik A, Kuziemski K, et al Impact of the COVID-19 pandemic on lung cancer diagnosis in northern
Poland-addressing the COVID-19 debt.
PLoS One. 2024;19:e0316261. PubMedAbstract available
SAIT ARW, AlBalawi E, Nagaraj R Ensemble learning driven Kolmogorov-Arnold Networks-based Lung Cancer
classification.
PLoS One. 2024;19:e0313386. PubMedAbstract available
SALAZAR P, Cheung P, Ganeshan B, Oikonomou A, et al Predefined and data-driven CT radiomics predict recurrence-free and overall
survival in patients with pulmonary metastases treated with stereotactic body
radiotherapy.
PLoS One. 2024;19:e0311910. PubMedAbstract available
SAETANG M, Kunapaisal T, Wasinwong W, Boonthum P, et al Predictors associated with Clavien-Dindo complications in lung cancer surgery: A
retrospective cohort study.
PLoS One. 2024;19:e0316214. PubMedAbstract available
DU L, Ren W, Liu L, Zhu H, et al SH2D5 promotes lung adenocarcinoma cell metastasis and triggers EMT via
activating AKT signaling pathway.
PLoS One. 2024;19:e0316432. PubMedAbstract available
January 2023
LIU Y Identification and comprehensive analysis of super-enhancer related genes
involved in epithelial-to-mesenchymal transition in lung adenocarcinoma.
PLoS One. 2023;18:e0291088. PubMedAbstract available
ZHOU D, Zhai X, Zhang R Ribonucleotide reductase regulatory subunit M2 (RRM2) as a potential
sero-diagnostic biomarker in non-small cell lung cancer.
PLoS One. 2023;18:e0291461. PubMedAbstract available
DAEI SORKHABI A, Fazlollahi A, Sarkesh A, Aletaha R, et al Efficacy and safety of veliparib plus chemotherapy for the treatment of lung
cancer: A systematic review of clinical trials.
PLoS One. 2023;18:e0291044. PubMedAbstract available
WU M, Liu S, Wang C, Wu Y, et al Risk factors for mortality among lung cancer patients with covid-19 infection: A
systematic review and meta-analysis.
PLoS One. 2023;18:e0291178. PubMedAbstract available
LIU Y, Yan M Trends in all causes and cause specific mortality attributable to ambient
particulate matter pollution in China from 1990 to 2019: A secondary data
analysis study.
PLoS One. 2023;18:e0291262. PubMedAbstract available
Retraction: Frondoside A Suppressive Effects on Lung Cancer Survival, Tumor
Growth, Angiogenesis, Invasion, and Metastasis.
PLoS One. 2023;18:e0291478. PubMed
FUJIKAWA K, Saito T, Kurose K, Kojima T, et al Integrated analysis of phase 1a and 1b randomized controlled trials;
Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody,
KW-0761, for advanced solid tumors.
PLoS One. 2023;18:e0291772. PubMedAbstract available
LEROY K, Audigier Valette C, Alexandre J, Boussemart L, et al Retrospective analysis of real-world data to evaluate actionability of a
comprehensive molecular profiling panel in solid tumor tissue samples (REALM
study).
PLoS One. 2023;18:e0291495. PubMedAbstract available
BINGHAM SL, Small S, Semple CJ A qualitative evaluation of a multi-modal cancer prehabilitation programme for
colorectal, head and neck and lung cancers patients.
PLoS One. 2023;18:e0277589. PubMedAbstract available
IKEMOTO S, Sakurai F, Tokuoka S, Yamashita T, et al Novel conditionally replicating adenovirus-mediated efficient detection of
circulating tumor cells in lung cancer patients.
PLoS One. 2023;18:e0286323. PubMedAbstract available
WESTEEL V, Schuette W, Urban T, Radonjic D, et al Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial
after first-line chemotherapy failure in NSCLC.
PLoS One. 2023;18:e0292307. PubMedAbstract available
ROUNIS K, Makrakis D, Papadaki C, Monastirioti A, et al Correction: Prediction of outcome in patients with non-small cell lung cancer
treated with second line PD-1/PDL-1 inhibitors based on clinical parameters:
Results from a prospective, single institution study.
PLoS One. 2023;18:e0294382. PubMedAbstract available
MAKRAKIS D, Rounis K, Tsigkas AP, Georgiou A, et al Correction: Effect of body tissue composition on the outcome of patients with
metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
PLoS One. 2023;18:e0294384. PubMedAbstract available
PENG B, Ling X, Huang T, Wan J, et al HSP70 via HIF-1 alpha SUMOylation inhibits ferroptosis inducing lung cancer
recurrence after insufficient radiofrequency ablation.
PLoS One. 2023;18:e0294263. PubMedAbstract available
LIMBU S, McCloskey KE Stemness genes and miR-1247-3p expression associate with clinicopathological
parameters and prognosis in lung adenocarcinoma.
PLoS One. 2023;18:e0294171. PubMedAbstract available
AIN NAZIR NU, Shaukat MH, Luo R, Abbas SR, et al Novel breath biomarkers identification for early detection of hepatocellular
carcinoma and cirrhosis using ML tools and GCMS.
PLoS One. 2023;18:e0287465. PubMedAbstract available
NIBID L, Greco C, Cordelli E, Sabarese G, et al Deep pathomics: A new image-based tool for predicting response to treatment in
stage III non-small cell lung cancer.
PLoS One. 2023;18:e0294259. PubMedAbstract available
ARBEE-KALIDAS N, Moutlana HJ, Moodley Y, Kebalepile MM, et al The association between cardiopulmonary exercise testing and postoperative
outcomes in patients with lung cancer undergoing lung resection surgery: A
systematic review and meta-analysis.
PLoS One. 2023;18:e0295430. PubMedAbstract available
NEMLANDER E, Rosenblad A, Abedi E, Ekman S, et al Correction: Lung cancer prediction using machine learning on data from a symptom
e-questionnaire for never smokers, formers smokers and current smokers.
PLoS One. 2023;18:e0295780. PubMedAbstract available
WANG J, Wang H, Xu J, Song Q, et al Identification of protein signatures for lung cancer subtypes based on BPSO
method.
PLoS One. 2023;18:e0294243. PubMedAbstract available
WU YY, Shen WB, Li JW, Liu MY, et al Targeted metabolomics reveals the association between central carbon metabolism
and pulmonary nodules.
PLoS One. 2023;18:e0295276. PubMedAbstract available
Retraction: Restoration of Mal overcomes the defects of apoptosis in lung cancer
cells.
PLoS One. 2023;18:e0296552. PubMed
Correction: Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung
Cancer.
PLoS One. 2023;18:e0296477. PubMedAbstract available
TIAN W, Guo Q, Fu D, Ma X, et al Efficacy and safety profile of combining antiangiogenic agents with chemotherapy
in patients with advanced malignant pleural mesothelioma: A systematic review and
meta-analysis of randomized controlled trials.
PLoS One. 2023;18:e0295745. PubMedAbstract available